TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biolin Scientific AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
88,014
|
94,462
|
78,910 |
| Financial expenses |
264
|
318
|
309 |
| Earnings before taxes |
2,647
|
16,016
|
13,883 |
| EBITDA |
6,746
|
18,135
|
17,387 |
| Total assets |
96,525
|
95,734
|
81,468 |
| Current assets |
37,929
|
33,846
|
24,308 |
| Current liabilities |
20,939
|
19,793
|
18,680 |
| Equity capital |
74,918
|
75,249
|
62,237 |
| - share capital |
17,263
|
17,854
|
17,762 |
| Employees (average) |
22
|
24
|
21 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
77.6%
|
78.6%
|
76.4% |
| Turnover per employee |
4,001
|
3,936
|
3,758 |
| Profit as a percentage of turnover |
3.0%
|
17.0%
|
17.6% |
| Return on assets (ROA) |
3.0%
|
17.1%
|
17.4% |
| Current ratio |
181.1%
|
171.0%
|
130.1% |
| Return on equity (ROE) |
3.5%
|
21.3%
|
22.3% |
| Change turnover |
-3,323
|
15,146
|
7,452 |
| Change turnover % |
-4%
|
19%
|
10% |
| Chg. No. of employees |
-2
|
3
|
-2 |
| Chg. No. of employees % |
-8%
|
14%
|
-9% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.